Skip to main content
OpenTrials
Not Yet Recruiting

NCT Number: NCT07093242

Epigenetic Optimization Through Biofrequency Nutrition

Biomarker-based nutrition has demonstrated superior efficacy compared to population-level approaches in improving health outcomes. Biofrequency analysis, a non-invasive technique based on the detection of electromagnetic vibrational patterns in hair follicles, offers a promising avenue for rapid functional assessment of nutritional status and epigenetic signals without reliance on blood or urine sampling. First, to evaluate the effect of a 90-day biofrequency-guided nutritional intervention on functional epigenetic status, as reflected in changes in the optimization report generated by the S-Drive system; second, to assess changes in adherence to the Mediterranean diet, anthropometric indicators, movement behaviors, and psychological well-being. Methods: In this randomized controlled trial, adults from a Sport Team from Region of Murcia (Spain) will be allocated to an experimental group receiving individualized lifestyle recommendations based on S-Drive biofrequency analysis and to a control group with no intervention. Participants in the experimental arm will apply tailored dietary guidance over 90 days. Conclusion: This study will generate foundational evidence on the utility of biofrequency technology for precision nutrition. If positive, the findings may inform scalable, low-risk strategies for personalized dietary interventions in preventive and community health settings.

Not Yet Recruiting

Trial opening soon.

Get Notified

Key information

Age range

18 year–65 year

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Age between 18 and 65 years.
  • Active member of a registered athletics club.
  • Willingness to provide a hair sample for genetic analysis.
  • Ability to understand and sign the informed consent form.
  • Commitment to complete the nutritional follow-up (for the intervention group) and to respond to pre- and post-intervention questionnaires.

Exclusion criteria

  • Prior medical diagnosis of a genetic disorder affecting nutritional metabolism.
  • Current use of nutritional supplements or special diets prescribed for medical reasons.
  • Participation in another clinical or nutritional study during the intervention period.
  • Pregnancy or breastfeeding at the time of enrollment.
  • Inability to attend baseline or post-intervention assessments.

Treatment and study plan

Personalized Nutritional Follow-Up

Behavioral

Participants in the experimental arm will receive a individual nutritional follow-up based on their epigenetic hair analysis results. This includes dietary guidance, recommendations tailored to genetic markers, and periodic consultations with a nutritionist over 4 weeks and continuous availability to clarify doubts via email . The aim is to evaluate changes in genetic expression or health biomarkers after the intervention period.

Primary outcomes

  1. Change in biofrequency-derived epigenetic markers related to nutritional metabolism

    Time frame: baseline and after 12-weeks post-intervention

    This outcome evaluates the correlation between the nutritional intervention and functional epigenetic status, assessed through the S-Drive optimization report. The measurement tool is the S-Drive system (Cell Wellbeing, Germany), a non-invasive device that analyzes resonance frequency patterns from hair follicle samples using proprietary bioinformatic algorithms. The report classifies physiological function into 12 domains related to nutritional metabolism (e.g., micronutrients, oxidative stress, circulatory function), assigning ordinal values to each: "not flagged" (0), "to be considered" (1), "advisable" (2), or "priority" (3). Two derived quantitative variables will be analyzed: (1) the number of domains classified as "priority" (unit: count, range: 0-12), and (2) the cumulative optimization score summing the ordinal ratings (unit: score, range: 0-36). These biofrequency will be used to assess within-subject changes and between group correlations from baseline to 90-day follow-up.

  2. Adherence to the Mediterranean Diet measured by the 14-item PREDIMED questionnaire

    Time frame: Baseline and after 12 weeks of intervention

    This outcome assesses adherence to the Mediterranean dietary pattern using the validated 14-item PREDIMED questionnaire (PREvención con DIeta MEDiterránea). Each item is scored as 0 (non-compliance) or 1 (compliance), for a total score ranging from 0 to 14. Higher scores indicate better adherence. The unit of measurement is the total PREDIMED score. A score ≥9 is considered high adherence. This variable will be measured at baseline and after the 90-day intervention to evaluate correlations between the individualized nutritional guidance and improvement in diet quality in the experimental group compared to the control group.

Study contacts

Contact information is provided by the study sponsor or research team.

David Manzano Sánchez

CONTACT

[email protected]

693353397 ext. +34

Leire Fradua Arteaga

CONTACT

[email protected]

644170100 ext. +34

Sponsors and collaborators

Lead sponsor

Universidad de Almeria

Other

Collaborators

  • Cell wellbeing

Registry information

Official study title

Functional Epigenetic Optimization Through Biofrequency-Guided Nutrition: A Randomized Controlled Trial

Important dates

Study start
2025
Primary completion
2025
Study completion
2026
First posted
Jul 30, 2025
Registry last updated
Jul 30, 2025

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.